Sen. Ron Wyden sold Pfizer (PFE)
Sen. Ron Wyden (D-OR) · $1K–$15K · traded Jun 3, 2025
Why this is a committee overlap
Wyden is the Ranking Member of the Senate Committee on Finance, which oversees Drug Manufacturers companies. Pfizer is classified in the Drug Manufacturers - General industry.
An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.
- Transaction
- Sold (full)
- Amount
- $1K–$15K
- Owner
- Spouse
- Traded
- Jun 3, 2025
- Disclosed
- Jul 2, 2025
- Days to disclose
- 29
- Asset type
- Stock
- As filed
- Pfizer, Inc. Common Stock
- Industry
- Drug Manufacturers - General · Healthcare
Recent Congress trades in PFE
- Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 9, 2026 · Spouse
- Oct 9, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 9, 2026 · Dependent
- Oct 9, 2026$15K–$50K
Rep. Ro Khanna (D-CA-17)
$15K–$50K · Traded Sep 4, 2026 · disclosed Oct 9, 2026 · Spouse
- Aug 14, 2026$15K–$50K
Rep. Carol D. Miller (R-WV-1)
$15K–$50K · Traded Mar 10, 2025 · disclosed Aug 14, 2026 · Spouse · filed 522 days later
- Aug 12, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Jul 7, 2026 · disclosed Aug 12, 2026 · Dependent
- Aug 10, 2026$1K–$15K
Rep. Michael A. Rulli (R-OH-6)
$1K–$15K · Traded Nov 26, 2024 · disclosed Aug 10, 2026 · filed 622 days later
- Jul 21, 2026$50K–$100K
Sen. Alan Armstrong (R-OK)
$50K–$100K · Traded Mar 24, 2026 · disclosed Jul 21, 2026 · filed 119 days later
Committee overlap: HELP - Jul 16, 2026$15K–$50K
Sen. Tommy Tuberville (R-AL)
$15K–$50K · Traded Jun 8, 2026 · disclosed Jul 16, 2026 · Joint
Committee overlap: HELP
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.